Table 3.
Protocol for sequential therapy of A-FMT with alginate drink or placebo.
|
Screening stage | Duration of administration | Post-observation | ||||
|---|---|---|---|---|---|---|---|
| Pre-registration (within 2 months) | Screening (within a month) | AFM | A-FMT | Alginate drink or Placebo | 6, 12, 18, and 24 months after | ||
| 2 weeks | 4 weeks after | 8 weeks after | |||||
| Informed consent | • | ||||||
| Check of patient background | • | ||||||
| Administration of study food | • | • | |||||
| Check of symptoms | • | • | • | • | • | • | |
| Endoscopy | • | • | • | ||||
| Blood samples | • | • | • | • | |||
| Fecal samples | • | • | • | • | |||
A-FMT, FMT following triple antibiotic therapy AFM (amoxicillin, fosfomycin, and metronidazole).